SC 13G
Amended Statement of Ownership
IRulya Therapeutics Inc. Filed Acc 0001140361-23-057682
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · Squadron Master Fund LP 8.8%
- 2026-11-16 SCHEDULE 13G/A · Ikarian Capital, LLC 2.3%
- 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 9.99%
- 2026-11-16 SCHEDULE 13G/A · SilverArc Capital Management, LLC 7.9%
- 2026-11-13 SCHEDULE 13G · SilverArc Capital Management, LLC 7.9%
Loading ef20016690_sc13g.htm…